- Home
- PYPD vs STEC Comparison
PYPD vs STEC Comparison
Compare PYPD & STEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PYPD
- STEC
- Stock Information
- Founded
- PYPD 2008
- STEC 2006
- Country
- PYPD Israel
- STEC China
- Employees
- PYPD N/A
- STEC N/A
- Industry
- PYPD Medical/Dental Instruments
- STEC
- Sector
- PYPD Health Care
- STEC
- Exchange
- PYPD Nasdaq
- STEC NYSE
- Market Cap
- PYPD 35.3M
- STEC 29.7M
- IPO Year
- PYPD 2020
- STEC 2021
- Fundamental
- Price
- PYPD $3.44
- STEC $0.89
- Analyst Decision
- PYPD Strong Buy
- STEC
- Analyst Count
- PYPD 5
- STEC 0
- Target Price
- PYPD $11.40
- STEC N/A
- AVG Volume (30 Days)
- PYPD 1.4M
- STEC 15.1K
- Earning Date
- PYPD 08-13-2025
- STEC 07-07-2025
- Dividend Yield
- PYPD N/A
- STEC N/A
- EPS Growth
- PYPD N/A
- STEC N/A
- EPS
- PYPD N/A
- STEC N/A
- Revenue
- PYPD N/A
- STEC $10,672,000.00
- Revenue This Year
- PYPD N/A
- STEC $9,392.20
- Revenue Next Year
- PYPD N/A
- STEC N/A
- P/E Ratio
- PYPD N/A
- STEC N/A
- Revenue Growth
- PYPD N/A
- STEC N/A
- 52 Week Low
- PYPD $2.30
- STEC $0.20
- 52 Week High
- PYPD $4.49
- STEC $3.25
- Technical
- Relative Strength Index (RSI)
- PYPD 56.85
- STEC 44.88
- Support Level
- PYPD $3.45
- STEC $0.76
- Resistance Level
- PYPD $3.62
- STEC $1.00
- Average True Range (ATR)
- PYPD 0.20
- STEC 0.10
- MACD
- PYPD -0.01
- STEC -0.01
- Stochastic Oscillator
- PYPD 63.57
- STEC 32.25
About PYPD PolyPid Ltd.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.
About STEC SANTECH HOLDINGS LIMITED
Santech Holdings Ltd is a customer based technology company. The company is engaged in exploring new opportunities in technology that includes new retail, social e-commerce, metaverse and others.